GSK - Aurinia Pharmaceuticals: Currently Presents An Excellent Entry Opportunity
- The price of Aurnia's shares is currently at an inflection point.
- I expect to see LupKynis sales figures skyrocket in the coming quarters.
- Aurinia currently presents an excellent investment opportunity, with huge upside potential, for the coming months/years.
For further details see:
Aurinia Pharmaceuticals: Currently Presents An Excellent Entry Opportunity